Michelle L. Tas

426 citations
4 papers · 78 indexed · h-index 4
Topics
Neuroblastoma Research and Treatments (4 papers)Lung Cancer Research Studies (4 papers)Cancer, Hypoxia, and Metabolism (2 papers)
Partner nations
NetherlandsUnited States

In The Last Decade

Michelle L. Tas

4 papers receiving 78 citations

Peers

Michelle L. Tas
Comparison fields: 5 of 24
  • Neurology 68
  • Molecular Biology 25
  • Cancer Research 24
  • Oncology 16
  • Pediatrics, Perinatology and Child Health 11
Replace Matthew Gianferante with:
Matthew Gianferante United States
Ellen Fraint United States
Anne Guimier France
Elen Oliveira Brazil
Illja J. Diets Netherlands
Naoko Takebe United States
Pietro Businaro Italy
Brent Coffey United States
Mirjam Blattner-Johnson Germany
Lorena Baroni Argentina
Michelle L. Tas relative to Matthew Gianferante United States Matthew Gianferante's profile →
Citations per field
00.5×1.5×2.3×
Matthew Gianferante · 1×
Citations per year

Countries citing papers authored by Michelle L. Tas

Since Specialization
Citations

This map shows the geographic impact of Michelle L. Tas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle L. Tas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle L. Tas more than expected).

Fields of papers citing papers by Michelle L. Tas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle L. Tas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle L. Tas. The network helps show where Michelle L. Tas may publish in the future.

Co-authorship network of co-authors of Michelle L. Tas

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle L. Tas. A scholar is included among the top collaborators of Michelle L. Tas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle L. Tas. Michelle L. Tas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
#WorkIndexed citations
1 11
2 3
3 16
4 48

About Michelle L. Tas

Michelle L. Tas is a scholar working on Neurology, Oncology and Cancer Research, having authored 4 papers that have together received 78 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (4 papers), Lung Cancer Research Studies (4 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Neurology (68 citations), Cancer Research (24 citations) and Genetics (9 citations). Michelle L. Tas has collaborated with scholars based in Netherlands and United States. Frequent co-authors include Kathelijne C.J.M. Kraal, Max M. van Noesel, Godelieve A.M. Tytgat, Bart de Keizer, Miranda P. Dierselhuis, J.W.W. Coebergh, Geert O. Janssens, Ronald R. de Krijger, Rob Pieters and Cornelis P. van de Ven. Their work appears in journals such as European Journal of Cancer, Cancers and Pediatric Blood & Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026